| Year |
Citation |
Score |
| 2024 |
Amontree M, Nelson M, Stefansson L, Pak D, Maguire-Zeiss K, Turner RS, Conant K. Resveratrol differentially affects MMP-9 release from neurons and glia; implications for therapeutic efficacy. Journal of Neurochemistry. PMID 38163875 DOI: 10.1111/jnc.16031 |
0.35 |
|
| 2020 |
Sánchez K, Maguire-Zeiss K. MMP13 Expression Is Increased Following Mutant α-Synuclein Exposure and Promotes Inflammatory Responses in Microglia. Frontiers in Neuroscience. 14: 585544. PMID 33343280 DOI: 10.3389/fnins.2020.585544 |
0.402 |
|
| 2019 |
Bozzelli PL, Yin T, Avdoshina V, Mocchetti I, Conant KE, Maguire-Zeiss KA. HIV-1 Tat promotes astrocytic release of CCL2 through MMP/PAR-1 signaling. Glia. PMID 31124192 DOI: 10.1002/Glia.23642 |
0.428 |
|
| 2017 |
Conant K, Daniele S, Bozzelli PL, Abdi T, Edwards A, Szklarczyk A, Olchefske I, Ottenheimer D, Maguire-Zeiss K. Matrix metalloproteinase activity stimulates N-cadherin shedding and the soluble N-cadherin ectodomain promotes classical microglial activation. Journal of Neuroinflammation. 14: 56. PMID 28302163 DOI: 10.1186/S12974-017-0827-4 |
0.406 |
|
| 2016 |
Allen M, Ghosh S, Ahern GP, Villapol S, Maguire-Zeiss KA, Conant K. Protease induced plasticity: matrix metalloproteinase-1 promotes neurostructural changes through activation of protease activated receptor 1. Scientific Reports. 6: 35497. PMID 27762280 DOI: 10.1038/Srep35497 |
0.362 |
|
| 2013 |
Béraud D, Hathaway HA, Trecki J, Chasovskikh S, Johnson DA, Johnson JA, Federoff HJ, Shimoji M, Mhyre TR, Maguire-Zeiss KA. Microglial activation and antioxidant responses induced by the Parkinson's disease protein α-synuclein. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 94-117. PMID 23054368 DOI: 10.1007/S11481-012-9401-0 |
0.331 |
|
| 2012 |
Conant K, Lim ST, Randall B, Maguire-Zeiss KA. Matrix metalloproteinase dependent cleavage of cell adhesion molecules in the pathogenesis of CNS dysfunction with HIV and methamphetamine. Current Hiv Research. 10: 384-91. PMID 22591362 DOI: 10.2174/157016212802138733 |
0.38 |
|
| 2011 |
Feng LR, Maguire-Zeiss KA. Dopamine and paraquat enhance α-synuclein-induced alterations in membrane conductance. Neurotoxicity Research. 20: 387-401. PMID 21735318 DOI: 10.1007/s12640-011-9255-x |
0.398 |
|
| 2011 |
Conant K, Lonskaya I, Szklarczyk A, Krall C, Steiner J, Maguire-Zeiss K, Lim ST. Methamphetamine-associated cleavage of the synaptic adhesion molecule intercellular adhesion molecule-5. Journal of Neurochemistry. 118: 521-32. PMID 21166806 DOI: 10.1111/J.1471-4159.2010.07153.X |
0.379 |
|
| 2010 |
Khandelwal PJ, Dumanis SB, Feng LR, Maguire-Zeiss K, Rebeck G, Lashuel HA, Moussa CE. Parkinson-related parkin reduces α-Synuclein phosphorylation in a gene transfer model. Molecular Neurodegeneration. 5: 47. PMID 21050448 DOI: 10.1186/1750-1326-5-47 |
0.418 |
|
| 2010 |
Feng LR, Federoff HJ, Vicini S, Maguire-Zeiss KA. Alpha-synuclein mediates alterations in membrane conductance: a potential role for alpha-synuclein oligomers in cell vulnerability. The European Journal of Neuroscience. 32: 10-7. PMID 20550572 DOI: 10.1111/J.1460-9568.2010.07266.X |
0.33 |
|
| 2010 |
Maguire-Zeiss KA, Federoff HJ. Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 117: 1019-25. PMID 20549523 DOI: 10.1007/S00702-010-0431-6 |
0.323 |
|
| 2010 |
Feng LR, Maguire-Zeiss KA. Gene therapy in Parkinson's disease: rationale and current status. Cns Drugs. 24: 177-92. PMID 20155994 DOI: 10.2165/11533740-000000000-00000 |
0.364 |
|
| 2009 |
Federoff HJ, Brown M, Dakshanamurthy S, Maguire-Zeiss K. Potential of Nurr1 interactions to disclose new Parkinson's therapeutics Future Neurology. 4: 161-165. DOI: 10.2217/14796708.4.2.161 |
0.335 |
|
| 2008 |
Su X, Maguire-Zeiss KA, Giuliano R, Prifti L, Venkatesh K, Federoff HJ. Synuclein activates microglia in a model of Parkinson's disease. Neurobiology of Aging. 29: 1690-701. PMID 17537546 DOI: 10.1016/J.Neurobiolaging.2007.04.006 |
0.33 |
|
| 2005 |
Maguire-Zeiss KA, Short DW, Federoff HJ. Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease? Brain Research. Molecular Brain Research. 134: 18-23. PMID 15790526 DOI: 10.1016/J.Molbrainres.2004.09.014 |
0.302 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2008 |
Johnston LC, Su X, Maguire-Zeiss K, Horovitz K, Ankoudinova I, Guschin D, Hadaczek P, Federoff HJ, Bankiewicz K, Forsayeth J. Human interleukin-10 gene transfer is protective in a rat model of Parkinson's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1392-9. PMID 18545225 DOI: 10.1038/Mt.2008.113 |
0.29 |
|
| 2009 |
Su X, Federoff HJ, Maguire-Zeiss KA. Mutant alpha-synuclein overexpression mediates early proinflammatory activity. Neurotoxicity Research. 16: 238-54. PMID 19526281 DOI: 10.1007/S12640-009-9053-X |
0.288 |
|
| 2014 |
Savolainen MH, Richie CT, Harvey BK, Männistö PT, Maguire-Zeiss KA, Myöhänen TT. The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse. Neurobiology of Disease. 68: 1-15. PMID 24746855 DOI: 10.1016/J.Nbd.2014.04.003 |
0.276 |
|
| 2009 |
Hathaway H, Feng L, Federoff H, Mhyre T, Maguire-Zeiss K. P3.190 The role of early oxidative stress events in Parkinson's disease Parkinsonism & Related Disorders. 15: S197. DOI: 10.1016/S1353-8020(09)70754-0 |
0.275 |
|
| 2003 |
Maguire-Zeiss KA, Federoff HJ. Convergent pathobiologic model of Parkinson's disease. Annals of the New York Academy of Sciences. 991: 152-66. PMID 12846984 DOI: 10.1111/J.1749-6632.2003.Tb07473.X |
0.264 |
|
| 2011 |
Béraud D, Twomey M, Bloom B, Mittereder A, Ton V, Neitzke K, Chasovskikh S, Mhyre TR, Maguire-Zeiss KA. α-Synuclein Alters Toll-Like Receptor Expression. Frontiers in Neuroscience. 5: 80. PMID 21747756 DOI: 10.3389/Fnins.2011.00080 |
0.263 |
|
| 2013 |
Huang L, Shimoji M, Wang J, Shah S, Kamila S, Biehl ER, Lim S, Chang A, Maguire-Zeiss KA, Su X, Federoff HJ. Development of inducible leucine-rich repeat kinase 2 (LRRK2) cell lines for therapeutics development in Parkinson's disease. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 10: 840-51. PMID 23963789 DOI: 10.1007/S13311-013-0208-3 |
0.262 |
|
| 2021 |
Vogiatzis S, Celestino M, Trevisan M, Magro G, Del Vecchio C, Erdengiz D, Palù G, Parolin C, Maguire-Zeiss K, Calistri A. Lentiviral Vectors Expressing Chimeric NEDD4 Ubiquitin Ligases: An Innovative Approach for Interfering with Alpha-Synuclein Accumulation. Cells. 10. PMID 34831478 DOI: 10.3390/cells10113256 |
0.257 |
|
| 2009 |
Maguire-Zeiss KA, Federoff HJ. Immune-directed gene therapeutic development for Alzheimer's, prion, and Parkinson's diseases. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 4: 298-308. PMID 18931916 DOI: 10.1007/S11481-008-9133-3 |
0.251 |
|
| 2008 |
Maguire-Zeiss KA, Mhyre TR, Federoff HJ. Gazing into the future: Parkinson's disease gene therapeutics to modify natural history. Experimental Neurology. 209: 101-13. PMID 18035353 DOI: 10.1016/J.Expneurol.2007.09.030 |
0.25 |
|
| 2012 |
Mhyre TR, Boyd JT, Hamill RW, Maguire-Zeiss KA. Parkinson's disease. Sub-Cellular Biochemistry. 65: 389-455. PMID 23225012 DOI: 10.1007/978-94-007-5416-4_16 |
0.25 |
|
| 2006 |
Maguire-Zeiss KA, Wang CI, Yehling E, Sullivan MA, Short DW, Su X, Gouzer G, Henricksen LA, Wuertzer CA, Federoff HJ. Identification of human alpha-synuclein specific single chain antibodies. Biochemical and Biophysical Research Communications. 349: 1198-205. PMID 16973126 DOI: 10.1016/J.Bbrc.2006.08.127 |
0.225 |
|
| 2015 |
Daniele SG, Béraud D, Davenport C, Cheng K, Yin H, Maguire-Zeiss KA. Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders. Science Signaling. 8: ra45. PMID 25969543 DOI: 10.1126/Scisignal.2005965 |
0.219 |
|
| 2018 |
Caplan IF, Maguire-Zeiss KA. Toll-Like Receptor 2 Signaling and Current Approaches for Therapeutic Modulation in Synucleinopathies. Frontiers in Pharmacology. 9: 417. PMID 29780321 DOI: 10.3389/fphar.2018.00417 |
0.215 |
|
| 2010 |
Lee BD, Shin JH, VanKampen J, Petrucelli L, West AB, Ko HS, Lee YI, Maguire-Zeiss KA, Bowers WJ, Federoff HJ, Dawson VL, Dawson TM. Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease. Nature Medicine. 16: 998-1000. PMID 20729864 DOI: 10.1038/Nm.2199 |
0.214 |
|
| 2021 |
McCann MS, Fernandez HR, Flowers SA, Maguire-Zeiss KA. Polychlorinated biphenyls induce oxidative stress and metabolic responses in astrocytes. Neurotoxicology. 86: 59-68. PMID 34265337 DOI: 10.1016/j.neuro.2021.07.001 |
0.209 |
|
| 2021 |
McCann MS, Fernandez HR, Flowers SA, Maguire-Zeiss KA. Polychlorinated biphenyls induce oxidative stress and metabolic responses in astrocytes. Neurotoxicology. 86: 59-68. PMID 34265337 DOI: 10.1016/j.neuro.2021.07.001 |
0.209 |
|
| 2007 |
Sortwell CE, Bowers WJ, Counts SE, Pitzer MR, Fleming MF, McGuire SO, Maguire-Zeiss KA, Federoff HJ, Collier TJ. Effects of ex vivo transduction of mesencephalic reaggregates with bcl-2 on grafted dopamine neuron survival. Brain Research. 1134: 33-44. PMID 17196186 DOI: 10.1016/J.Brainres.2006.11.079 |
0.206 |
|
| 2008 |
Maguire-Zeiss KA. alpha-Synuclein: a therapeutic target for Parkinson's disease? Pharmacological Research. 58: 271-80. PMID 18840530 DOI: 10.1016/j.phrs.2008.09.006 |
0.202 |
|
| 2012 |
Béraud D, Maguire-Zeiss KA. Misfolded α-synuclein and Toll-like receptors: therapeutic targets for Parkinson's disease. Parkinsonism & Related Disorders. 18: S17-20. PMID 22166424 DOI: 10.1016/S1353-8020(11)70008-6 |
0.199 |
|
| 2023 |
Morrison V, Houpert M, Trapani J, Brockman A, Kingsley P, Katdare K, Layden H, Nguena-Jones G, Trevisan A, Maguire-Zeiss K, Marnett L, Bix G, Ihrie R, Carter B. Jedi-1/MEGF12-mediated phagocytosis controls the pro-neurogenic properties of microglia in the ventricular-subventricular zone. Cell Reports. 42: 113423. PMID 37952151 DOI: 10.1016/j.celrep.2023.113423 |
0.193 |
|
| 2006 |
Bowers WJ, Mastrangelo MA, Howard DF, Southerland HA, Maguire-Zeiss KA, Federoff HJ. Neuronal precursor-restricted transduction via in utero CNS gene delivery of a novel bipartite HSV amplicon/transposase hybrid vector. Molecular Therapy : the Journal of the American Society of Gene Therapy. 13: 580-8. PMID 16412694 DOI: 10.1016/J.Ymthe.2005.11.011 |
0.193 |
|
| 2021 |
McCann MS, Maguire-Zeiss KA. Environmental toxicants in the brain: A review of astrocytic metabolic dysfunction. Environmental Toxicology and Pharmacology. 84: 103608. PMID 33556584 DOI: 10.1016/j.etap.2021.103608 |
0.181 |
|
| 2008 |
Mhyre TR, Loy R, Tariot PN, Profenno LA, Maguire-Zeiss KA, Zhang D, Coleman PD, Federoff HJ. Proteomic analysis of peripheral leukocytes in Alzheimer's disease patients treated with divalproex sodium. Neurobiology of Aging. 29: 1631-43. PMID 17521776 DOI: 10.1016/J.Neurobiolaging.2007.04.004 |
0.177 |
|
| 2023 |
Morrison VE, Houpert MG, Trapani JB, Brockman AA, Kingsley PJ, Katdare KA, Layden HM, Nguena-Jones G, Trevisan AJ, Maguire-Zeiss KA, Marnett LJ, Bixa GJ, Ihrie RA, Carter BD. Jedi-1/MEGF12-mediated phagocytosis controls the pro-neurogenic properties of microglia in the ventricular-subventricular zone. Biorxiv : the Preprint Server For Biology. PMID 36945622 DOI: 10.1101/2023.03.03.531012 |
0.172 |
|
| 2004 |
Maguire-Zeiss KA, Federoff HJ. Safety of viral vectors for neurological gene therapies. Current Opinion in Molecular Therapeutics. 6: 473-81. PMID 15537048 |
0.159 |
|
| 2002 |
Maguire-Zeiss KA, Bowers WJ, Federoff HJ. Somatic mosaic approaches and the aging brain. Neurobiology of Aging. 23: 977-84. PMID 12392799 DOI: 10.1016/S0197-4580(02)00077-5 |
0.158 |
|
| 2017 |
Winland CD, Welsh N, Sepulveda-Rodriguez A, Vicini S, Maguire-Zeiss KA. Inflammation alters AMPA-stimulated calcium responses in dorsal striatal D2 but not D1 spiny projection neurons. The European Journal of Neuroscience. PMID 28921719 DOI: 10.1111/Ejn.13711 |
0.15 |
|
| 2014 |
Ullrich L, Dumanis SB, Evans TM, Jeannotte AM, Leonard C, Rozzi SJ, Taylor CM, Gale K, Kanwal JS, Maguire-Zeiss KA, Wolfe BB, Forcelli PA. From student to steward: the Interdisciplinary Program in Neuroscience at Georgetown University as a case study in professional development during doctoral training. Medical Education Online. 19: 22623. PMID 28440177 DOI: 10.3402/meo.v19.22623 |
0.064 |
|
| 2014 |
Ullrich L, Dumanis SB, Evans TM, Jeannotte AM, Leonard C, Rozzi SJ, Taylor CM, Gale K, Kanwal JS, Maguire-Zeiss KA, Wolfe BB, Forcelli PA. From student to steward: the Interdisciplinary Program in Neuroscience at Georgetown University as a case study in professional development during doctoral training. Medical Education Online. 19: 22623. PMID 25005356 DOI: 10.3402/Meo.V19.22623 |
0.064 |
|
| 2014 |
Daniele SG, Edwards AA, Maguire-Zeiss KA. Isolation of cortical microglia with preserved immunophenotype and functionality from murine neonates. Journal of Visualized Experiments : Jove. e51005. PMID 24513797 DOI: 10.3791/51005 |
0.017 |
|
| Hide low-probability matches. |